Cardiac Fibrosis: Mechanistic Discoveries Linked to SGLT2 Inhibitors
Sodium-glucose cotransporter 2 inhibitors (SGLT2is), commonly known as flozins, have garnered attention not only for their glucose-lowering effects in type 2 diabetes mellitus (T2DM) but also for their cardioprotective properties. This review examines the mechanisms underlying the anti-fibrotic effe...
| Published in: | Pharmaceuticals |
|---|---|
| Main Authors: | , |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-02-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/18/3/313 |